atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit

Rhea-AI Summary

atai Life Sciences (NASDAQ: ATAI), a clinical-stage biopharmaceutical company focused on transforming mental health disorder treatments, has announced its participation in the 2024 Maxim Healthcare Virtual Summit. The event is scheduled from October 15 – 17, 2024.

Key details of atai's involvement include:

• Participant: Srinivas Rao, M.D., Ph.D., Co-founder and Co-CEO
• Format: Virtual fireside chat
• Date: Wednesday, October 16, 2024
• Presentation Time: 3:30 P.M. EDT

A webcast registration link is provided, and an archived replay will be available on the Investors section of atai's website under Events for up to 30 days after the presentation.

News Market Reaction – ATAI

-0.91%

-0.91% Session move

In the trading session that priced this news, ATAI declined 0.91%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK and BERLIN, Oct. 15, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that Srinivas Rao, M.D., Ph.D., the Company’s Co-founder and Co-CEO, is scheduled to participate in the 2024 Maxim Healthcare Virtual Summit taking place from October 15 – 17, 2024. Details of the company’s participation:

Format: Virtual fireside chat
Date: Wednesday, October 16, 2024
Presentation Time: 3:30 P.M. EDT
Webcast: Register here

An archived replay will be available on the Investors section of the atai website under Events for up to 30 days.

About atai Life Sciences

atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders and was founded as a response to the significant unmet need and lack of innovation in the mental health treatment landscape. atai is dedicated to efficiently developing innovative therapeutics to treat depression, anxiety, addiction, and other mental health disorders. By pooling resources and best practices, atai aims to responsibly accelerate the development of new medicines to achieve clinically meaningful and sustained behavioral change in mental health patients. atai's vision is to heal mental health disorders so that everyone, everywhere can live a more fulfilled life. For more information, please visit www.atai.life.

Contact Information

Investor Contact:
IR@atai.life

Media Contact:
PR@atai.life

FAQ

When is atai Life Sciences (ATAI) participating in the 2024 Maxim Healthcare Virtual Summit?

atai Life Sciences (ATAI) is participating in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16, 2024, with a presentation time of 3:30 P.M. EDT.

Who will be representing atai Life Sciences (ATAI) at the 2024 Maxim Healthcare Virtual Summit?

Srinivas Rao, M.D., Ph.D., the Co-founder and Co-CEO of atai Life Sciences, will be representing the company at the 2024 Maxim Healthcare Virtual Summit.

What is the format of atai Life Sciences' (ATAI) presentation at the 2024 Maxim Healthcare Virtual Summit?

atai Life Sciences' (ATAI) presentation at the 2024 Maxim Healthcare Virtual Summit will be in the format of a virtual fireside chat.

How long will the replay of atai Life Sciences' (ATAI) presentation be available?

An archived replay of atai Life Sciences' (ATAI) presentation will be available on the Investors section of the company's website under Events for up to 30 days after the presentation.